Research Articles
Calycosin's Cancer Breakthrough: How a Plant Compound Fights Kidney Cancer
Discover how calycosin, a plant-derived flavonoid, inhibits renal cell carcinoma by targeting the MAZ/HAS2 signaling pathway.
The Dark Particle: How a Brain Pigment Holds Clues to Parkinson's Disease
Exploring how neuromelanin organelles transform from cellular protectors to toxic agents in Parkinson's disease pathology.
The Silent Killers Within: Decoding Cancer, Aging and Inflammation at Cyprus' Premier Biomedical Congress
Coverage of the groundbreaking discoveries presented at the 6th International Multithematic Scientific Bio-Medical Congress in Cyprus, featuring Nobel Laureate Aaron Ciechanover and other leading researchers.
The Lethal Overdrive: How Supercharging Cancer Pathways Could Be Our Smartest Weapon Yet
Exploring how hyperactivating cancer pathways can be a novel synthetic lethality approach in oncology
Chemoprevention: Your Cells' Ultimate Chill-Out Pill?
Explore the revolutionary frontier of cancer chemoprevention - a strategy that helps your cells stay cancer-free through natural compounds and repurposed drugs.
MetaDegron: AI's Protein Prediction Powerhouse Reveals Cellular Recycling Secrets
Discover how MetaDegron's multimodal AI predicts cellular protein degradation signals (degrons) with unprecedented accuracy, opening new frontiers in drug discovery.
The Cancer Drug That Could Rescue Brains: How Bortezomib Offers New Hope for a Rare Genetic Disorder
Discover how bortezomib, a cancer drug, shows promise in treating Niemann-Pick Type C disease by rescuing misfolded NPC1 proteins and reducing cholesterol accumulation.
Unlocking Cancer's Shape-Shifting Secret: How a Single Protein Pulls the Strings in Ewing Sarcoma
Discover how EWS-FLI1 orchestrates Ewing sarcoma plasticity through a post-translational modification cascade regulating FOXM1 stability.
Unlocking p53's Potential: The Gene Signature Predicting Cancer Drug Success
Discover how a 13-gene signature predicts response to MDM2 inhibitors in p53 wild-type cancers, enabling personalized therapy approaches.
The Metabolic Maestro: How PKM2 and Matrin 3 Orchestrate a Cancer Symphony
Exploring how PKM2 phosphorylates Matrin 3 to promote FOXC2-mediated tumorigenesis in cancer metabolism.